Thus, even if the CD133+ cell population was drastically reduced during the tumor development process, prominin-1 expression in tumors was still eight times higher in the CD133+ group than in tumors derived from the CD133- fraction (2.6% vs. 0.29%, respectively; n=6) (Table S2). Here, PROM1 is linked to neoplasm.